Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test

Detalhes bibliográficos
Autor(a) principal: Castineiras,Terezinha Marta Pereira Pinto
Data de Publicação: 2021
Outros Autores: Nascimento,Érica Ramos dos Santos, Faffe,Débora Souza, Galliez,Rafael Mello, Mariani,Diana, Leitão,Isabela de Carvalho, Melo,Mayla Gabryele Miranda de, Ferreira,Orlando Costa, Tanuri,Amilcar
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Infectious Diseases
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000500204
Resumo: ABSTRACT Introduction: In the current standard of care (SoC) RT-PCR method for COVID-19, the patient’s swab was extracted in viral transport media (VTM). For the PanbioTM COVID-19 Ag Rapid Test, the patient swab is flushed out in extraction buffer, of which a small fraction is used for testing, leaving more than half the sample unused. This study was designed to show that RT-PCR results from the residual sample of the PanbioTM COVID-19 Ag Rapid Test (called Novel RT-PCR) are not worse than the SoC RT-PCR result. Methods: The study was performed using (1) dilution series of five patient samples, and (2) 413 patient samples comparing SOC versus Novel RT-PCR results. Results: For the dilution series samples, all tested positive by both methods. The bias between Ct values of Novel RT-PCR and SoC RT-PCR did not exceed 3.00 Ct using primers N1 and N2. A total of 413 COVID symptomatic patients seeking COVID testing were tested, of which 89 patients tested positive and 324 tested negative with SoC RT-PCR. In 324 patients who tested negative with SoC RT-PCR, 323 tested negative with Novel RT-PCR, and one (1) tested positive. Out of 89 who tested positive with SoC RT-PCR, 80 tested positive with the Novel RT-PCR, and nine patients showed a negative test result. The Overall Percent Agreement for the 413 valid patient sample pairs was 97.5 [95% CI 97 to 98]. Conclusion: The study demonstrated that the performance of the Novel RT-PCR method is acceptable compared to the SoC RT-PCR method and can be a useful tool to perform RTPCR without the need for new swab collections.
id BSID-1_53a3c068b66e2c1dfff05aa0d3586e66
oai_identifier_str oai:scielo:S1413-86702021000500204
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 testCOVID-19Antigen rapid testRT-PCRABSTRACT Introduction: In the current standard of care (SoC) RT-PCR method for COVID-19, the patient’s swab was extracted in viral transport media (VTM). For the PanbioTM COVID-19 Ag Rapid Test, the patient swab is flushed out in extraction buffer, of which a small fraction is used for testing, leaving more than half the sample unused. This study was designed to show that RT-PCR results from the residual sample of the PanbioTM COVID-19 Ag Rapid Test (called Novel RT-PCR) are not worse than the SoC RT-PCR result. Methods: The study was performed using (1) dilution series of five patient samples, and (2) 413 patient samples comparing SOC versus Novel RT-PCR results. Results: For the dilution series samples, all tested positive by both methods. The bias between Ct values of Novel RT-PCR and SoC RT-PCR did not exceed 3.00 Ct using primers N1 and N2. A total of 413 COVID symptomatic patients seeking COVID testing were tested, of which 89 patients tested positive and 324 tested negative with SoC RT-PCR. In 324 patients who tested negative with SoC RT-PCR, 323 tested negative with Novel RT-PCR, and one (1) tested positive. Out of 89 who tested positive with SoC RT-PCR, 80 tested positive with the Novel RT-PCR, and nine patients showed a negative test result. The Overall Percent Agreement for the 413 valid patient sample pairs was 97.5 [95% CI 97 to 98]. Conclusion: The study demonstrated that the performance of the Novel RT-PCR method is acceptable compared to the SoC RT-PCR method and can be a useful tool to perform RTPCR without the need for new swab collections.Brazilian Society of Infectious Diseases2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000500204Brazilian Journal of Infectious Diseases v.25 n.5 2021reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2021.101630info:eu-repo/semantics/openAccessCastineiras,Terezinha Marta Pereira PintoNascimento,Érica Ramos dos SantosFaffe,Débora SouzaGalliez,Rafael MelloMariani,DianaLeitão,Isabela de CarvalhoMelo,Mayla Gabryele Miranda deFerreira,Orlando CostaTanuri,Amilcareng2021-11-25T00:00:00Zoai:scielo:S1413-86702021000500204Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2021-11-25T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test
title Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test
spellingShingle Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test
Castineiras,Terezinha Marta Pereira Pinto
COVID-19
Antigen rapid test
RT-PCR
title_short Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test
title_full Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test
title_fullStr Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test
title_full_unstemmed Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test
title_sort Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test
author Castineiras,Terezinha Marta Pereira Pinto
author_facet Castineiras,Terezinha Marta Pereira Pinto
Nascimento,Érica Ramos dos Santos
Faffe,Débora Souza
Galliez,Rafael Mello
Mariani,Diana
Leitão,Isabela de Carvalho
Melo,Mayla Gabryele Miranda de
Ferreira,Orlando Costa
Tanuri,Amilcar
author_role author
author2 Nascimento,Érica Ramos dos Santos
Faffe,Débora Souza
Galliez,Rafael Mello
Mariani,Diana
Leitão,Isabela de Carvalho
Melo,Mayla Gabryele Miranda de
Ferreira,Orlando Costa
Tanuri,Amilcar
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Castineiras,Terezinha Marta Pereira Pinto
Nascimento,Érica Ramos dos Santos
Faffe,Débora Souza
Galliez,Rafael Mello
Mariani,Diana
Leitão,Isabela de Carvalho
Melo,Mayla Gabryele Miranda de
Ferreira,Orlando Costa
Tanuri,Amilcar
dc.subject.por.fl_str_mv COVID-19
Antigen rapid test
RT-PCR
topic COVID-19
Antigen rapid test
RT-PCR
description ABSTRACT Introduction: In the current standard of care (SoC) RT-PCR method for COVID-19, the patient’s swab was extracted in viral transport media (VTM). For the PanbioTM COVID-19 Ag Rapid Test, the patient swab is flushed out in extraction buffer, of which a small fraction is used for testing, leaving more than half the sample unused. This study was designed to show that RT-PCR results from the residual sample of the PanbioTM COVID-19 Ag Rapid Test (called Novel RT-PCR) are not worse than the SoC RT-PCR result. Methods: The study was performed using (1) dilution series of five patient samples, and (2) 413 patient samples comparing SOC versus Novel RT-PCR results. Results: For the dilution series samples, all tested positive by both methods. The bias between Ct values of Novel RT-PCR and SoC RT-PCR did not exceed 3.00 Ct using primers N1 and N2. A total of 413 COVID symptomatic patients seeking COVID testing were tested, of which 89 patients tested positive and 324 tested negative with SoC RT-PCR. In 324 patients who tested negative with SoC RT-PCR, 323 tested negative with Novel RT-PCR, and one (1) tested positive. Out of 89 who tested positive with SoC RT-PCR, 80 tested positive with the Novel RT-PCR, and nine patients showed a negative test result. The Overall Percent Agreement for the 413 valid patient sample pairs was 97.5 [95% CI 97 to 98]. Conclusion: The study demonstrated that the performance of the Novel RT-PCR method is acceptable compared to the SoC RT-PCR method and can be a useful tool to perform RTPCR without the need for new swab collections.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000500204
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000500204
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1016/j.bjid.2021.101630
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.25 n.5 2021
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209245389127680